The negative screening for AADC deficiency in examined subjects highlights that the population to be investigated for this rare condition should be a larger cohort and should have more defined clinical features, for example, the association with common signs such as hypotonia and/or pathognomonic symptoms such as oculogyric crisis and dysautonomia. This evidence concerns the gene DDC and dysautonomia.